William Tew, PhD (CEO) Over 40 Years of entrepreneurial experience. Founder of Chesapeake Biological Laboratories, Glycosan BioSystems (now part of BioTime). Associate Provost/Assistant Dean of Technology Licensing at the Johns Hopkins University.
Thomas Kennedy, MD, MPH (CMO) Physician and Inventor. Expert in glycosaminoglycan biology. Dr. Kennedy is a co-founder of GlycoMira Therapeutics and ParinGenix (now Cantex Pharma, FL). He received his MD from Vanderbilt University and trainings from the Johns Hopkins Hospital.
Jeremiah Alt, MD, PhD (Director of Respiratory Clinical Development)
Glenn Prestwich, PhD (CSO) Presidential Professor, and Director of Center for Therapeutic Biomaterials at the University of Utah. Dr. Prestwich is a co-founder of GlycoMira, Echelon Biosciences, Glycosan BioSystems, Sentrix Animal Care. He also serves as Chief Science Officer at Symic Bio.
Justin Savage, PhD (VP Operations) Dr. Savage serves as GlycoMira’s Vice President of Operations. He earned his doctorate degree in Biochemistry from Brigham Young University.
Won Yong Lee, DVM, MS, PhD (Director of R&D) Dr. Lee has been leading our R&D. He has high quality scientific achievements throughout his academic career (including two Nature articles). A Mayo Clinic alum (Ph.D. in neuroscience).
Abigail Pulsipher, PhD (Director of Respiratory Research & Development) Dr. Pulsipher received a PhD in Chemistry from the UNC Chapel Hill and completed postdoctoral training at Caltech.